These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8226493)

  • 1. Cholinergic and opioid involvement in release of growth hormone during exercise and recovery.
    Thompson DL; Weltman JY; Rogol AD; Metzger DL; Veldhuis JD; Weltman A
    J Appl Physiol (1985); 1993 Aug; 75(2):870-8. PubMed ID: 8226493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of brief exercise on circulating insulin-like growth factor I.
    Cappon J; Brasel JA; Mohan S; Cooper DM
    J Appl Physiol (1985); 1994 Jun; 76(6):2490-6. PubMed ID: 7928875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low and high intensity exercise on circulating growth hormone in men.
    Felsing NE; Brasel JA; Cooper DM
    J Clin Endocrinol Metab; 1992 Jul; 75(1):157-62. PubMed ID: 1619005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man.
    Cappa M; Grossi A; Benedetti S; Drago F; Loche S; Ghigo E
    J Endocrinol Invest; 1993 Jun; 16(6):421-4. PubMed ID: 8370917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of high fat and high glucose meals on the growth hormone response to exercise.
    Cappon JP; Ipp E; Brasel JA; Cooper DM
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1418-22. PubMed ID: 8501145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement.
    Wehrenberg WB; Wiviott SD; Voltz DM; Giustina A
    Endocrinology; 1992 Mar; 130(3):1445-50. PubMed ID: 1347008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of exercise performed before and 24 hours after blood withdrawal on serum erythropoietin and growth hormone concentrations in humans.
    Duda K; Zoladz JA; Majerczak J; Kolodziejski L; Konturek SJ
    Int J Sports Med; 2003 Jul; 24(5):326-31. PubMed ID: 12868042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of endogenous opioids on the response of selected hormones to exercise in humans.
    Farrell PA; Gustafson AB; Garthwaite TL; Kalkhoff RK; Cowley AW; Morgan WP
    J Appl Physiol (1985); 1986 Sep; 61(3):1051-7. PubMed ID: 3759744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol and growth hormone responses to exercise at different times of day.
    Kanaley JA; Weltman JY; Pieper KS; Weltman A; Hartman ML
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2881-9. PubMed ID: 11397904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower excess postexercise oxygen consumption and altered growth hormone and cortisol responses to exercise in obese men.
    Wong T; Harber V
    J Clin Endocrinol Metab; 2006 Feb; 91(2):678-86. PubMed ID: 16332937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blunted growth hormone response to maximal exercise in middle-aged versus young subjects and no effect of endurance training.
    Zaccaria M; Varnier M; Piazza P; Noventa D; Ermolao A
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2303-7. PubMed ID: 10404793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of IGF-I to endogenous increases in growth hormone after heavy-resistance exercise.
    Kraemer WJ; Aguilera BA; Terada M; Newton RU; Lynch JM; Rosendaal G; McBride JM; Gordon SE; Häkkinen K
    J Appl Physiol (1985); 1995 Oct; 79(4):1310-5. PubMed ID: 8567577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of glucose and pyridostigmine on the secretion of growth hormone (GH) induced by GH-releasing hormone (GHRH).
    Delitala G; Tomasi PA; Palermo M; Fresu P
    J Endocrinol Invest; 1990 Sep; 13(8):653-6. PubMed ID: 2273206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant status and indexes of oxidative stress during consecutive days of exercise.
    Viguie CA; Frei B; Shigenaga MK; Ames BN; Packer L; Brooks GA
    J Appl Physiol (1985); 1993 Aug; 75(2):566-72. PubMed ID: 7693646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans.
    Maier C; Schaller G; Buranyi B; Nowotny P; Geyer G; Wolzt M; Luger A
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4729-33. PubMed ID: 15356087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone replacement therapy in adults with growth hormone deficiency improves maximal oxygen consumption independently of dosing regimen or physical activity.
    Hartman ML; Weltman A; Zagar A; Qualy RL; Hoffman AR; Merriam GR
    J Clin Endocrinol Metab; 2008 Jan; 93(1):125-30. PubMed ID: 17956953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone.
    Giusti M; Marini G; Sessarego P; Peluffo F; Valenti S; Caratti C; Giordano G
    Recenti Prog Med; 1991 Dec; 82(12):665-8. PubMed ID: 1815302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women.
    Arvat E; Cappa M; Casanueva FF; Dieguez C; Ghigo E; Nicolosi M; Valcavi R; Zini M
    J Clin Endocrinol Metab; 1993 Feb; 76(2):374-7. PubMed ID: 8432781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.